About our research
Our integrated team of gastroenterology researchers, nurses and clinicians are at the forefront of gastroenterology research in the UK.
Research into inflammatory bowel disease (IBD) is a major strength across King’s Health Partners (KHP), bringing together several independently successful research groups: immunology, genetics, dieticians, psychiatry and clinical inflammatory bowel disease (IBD).
We have an international reputation as leaders and pioneers of optimised immunosuppression trials looking into IBD using pharmacogenetics (the study of inherited genetic differences in drug metabolic pathways which can affect individual responses to drugs).
We have also conducted research looking into new drug targets - which has shaped IBD practice across the globe (Taylor Nat Rev Gastroenterol Hepatol 2011, Heap Nature Genetics 2014). Together we are developing precision medicine approaches to improve patient care through several research trials.
If attending one of the outpatient clinics, please be aware that you may be invited to take part in one of our current studies. If you would like more information on any of the studies, please email us at email@example.com.
The NIHR Biomedical Research Centre Patient and Public Involvement Advisory Group (PPIAG) develops methods of engagement with the local population. They also provide a patient/public perspective on a variety of research practices and approaches.